LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q4 2022 Earnings Conference Call February 23, 2023 5:00 PM ET
Company Participants
J.J. Pellegrino - Chief Financial Officer
George LeMaitre - Chairman and Chief Executive Officer
Dave Roberts - President
Conference Call Participants
Matthew Mishan - KeyBanc
Michael Petusky - Barrington Research
Brooks O’Neil - Lake Street Capital
Jim Sidoti - Sidoti
Operator
Welcome to LeMaitre Vascular Q4 2022 Financial Results Conference Call. As a reminder, today’s call is being recorded. At this time, I would like to turn the call over to Mr. J.J. Pellegrino, Chief Financial Officer of LeMaitre Vascular. Go ahead, sir.
J.J. Pellegrino
Thank you operator. Good afternoon and thank you for joining us on our Q4 2022 conference call. With me on today’s call is our Chairman and CEO, George LeMaitre; and our President, Dave Roberts.
Before we begin, I’ll read our Safe Harbor statement. Today, we will make some forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, the accuracy of which is subject to risks and uncertainties. Wherever possible, we will try to identify those forward-looking statements by using words such as believe, expect, anticipate, pursue, forecast and similar expressions. Our forward-looking statements are based on our estimates and assumptions as of today, February 23, 2023, and should not be relied upon as representing our estimates or views on any subsequent date.
Please refer to the cautionary statement regarding forward-looking information and the risk factors in our most recent 10-K and subsequent SEC filings, including disclosure of the factors that could cause results to differ materially from those expressed or implied. During this call, we will discuss non-GAAP financial measures, which include organic sales growth as well as operating income, operating expense and EPS excluding special charges and gross margin, including the impact of foreign exchange. A reconciliation of
- Read more current LMAT analysis and news
- View all earnings call transcripts